InvestorsHub Logo
Followers 276
Posts 36090
Boards Moderated 2
Alias Born 04/05/2012

Re: None

Sunday, 12/08/2019 9:30:25 PM

Sunday, December 08, 2019 9:30:25 PM

Post# of 2793
Heres 8k Released after hrs friday ~>

On December 6, 2019, Sunesis and Denovo entered into a license agreement for vosaroxin pursuant to which Sunesis is eligible to receive an upfront payment, up to $57.0 million in regulatory and commercial milestones, and double-digit royalties on future sales of vosaroxin.

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.